Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2 09/28/2017 OBSERVATIONAL unchanged 3,254.85 0 The Effects of the Female Hormones on Cerebral Perfusion 10/02/2017 OBSERVATIONAL unchanged 3,250.85 0 Group Versus Traditional Prenatal Care for Diabetes 10/04/2017 INTERVENTIONAL unchanged 3,248.85 0 The Value of Advanced Imaging Sequences for Fetal MRI in Clinical Practice 10/05/2017 INTERVENTIONAL unchanged 3,247.85 0 Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients 10/06/2017 INTERVENTIONAL unchanged 3,246.85 0 The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial 10/11/2017 INTERVENTIONAL unchanged 3,241.85 0 Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study 10/13/2017 OBSERVATIONAL unchanged 3,239.85 0 Berlin-Brandenburg Pregnancy Cohort 10/18/2017 OBSERVATIONAL unchanged 3,234.85 0 Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery 10/23/2017 INTERVENTIONAL unchanged 3,229.85 0 Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness 10/25/2017 INTERVENTIONAL unchanged 3,227.85 0 Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer 10/27/2017 INTERVENTIONAL unchanged 3,225.85 0 Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer 10/30/2017 INTERVENTIONAL unchanged 3,222.85 0 Trial of Posture Correction Girdle for Adolescents With Early Scoliosis 11/06/2017 INTERVENTIONAL unchanged 3,215.85 0 A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer 11/06/2017 INTERVENTIONAL unchanged 3,215.85 0 Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes 11/06/2017 OBSERVATIONAL unchanged 3,215.85 0 High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study 11/17/2017 INTERVENTIONAL unchanged 3,204.85 0 Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection 11/17/2017 INTERVENTIONAL unchanged 3,204.85 0 Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer 11/21/2017 INTERVENTIONAL unchanged 3,200.85 0 Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control 11/22/2017 INTERVENTIONAL unchanged 3,199.85 0 An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants 11/29/2017 OBSERVATIONAL unchanged 3,192.85 0 Community-Based Lifestyle Intervention for Diabetes Prevention in Arab Women 12/02/2017 INTERVENTIONAL unchanged 3,189.85 0 Nurse-Family Partnership Impact Evaluation in South Carolina 12/04/2017 INTERVENTIONAL unchanged 3,187.85 0 PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer 12/05/2017 INTERVENTIONAL unchanged 3,186.85 0 Breast Cancer Study of Preoperative Pembrolizumab + Radiation 12/08/2017 INTERVENTIONAL unchanged 3,183.85 0 Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer 12/11/2017 INTERVENTIONAL unchanged 3,180.85 0 In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions 12/13/2017 INTERVENTIONAL unchanged 3,178.85 0 Breast Cancer Screening: Digital Breast Tomosynthesis Versus Digital 2D Mammography 12/19/2017 INTERVENTIONAL unchanged 3,172.85 0 Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer 12/19/2017 INTERVENTIONAL unchanged 3,172.85 0 Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer 12/20/2017 INTERVENTIONAL unchanged 3,171.85 0 Preservation of Ovarian Cortex Tissue in Girls With Turner Syndrome 12/21/2017 INTERVENTIONAL unchanged 3,170.85 0 Dexmedetomidine Wound Infiltration in Cesarean Section 12/26/2017 INTERVENTIONAL unchanged 3,165.85 0 International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer 12/29/2017 INTERVENTIONAL unchanged 3,162.85 0 Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies 01/04/2018 OBSERVATIONAL unchanged 3,156.85 0 Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) 01/05/2018 INTERVENTIONAL unchanged 3,155.85 0 Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) 01/09/2018 INTERVENTIONAL unchanged 3,151.85 0 Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes 01/10/2018 OBSERVATIONAL unchanged 3,150.85 0 Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer 01/17/2018 INTERVENTIONAL unchanged 3,143.85 0 Effects of Simvastatin on Uterine Leiomyoma Size 01/17/2018 INTERVENTIONAL unchanged 3,143.85 0 Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome 01/17/2018 INTERVENTIONAL unchanged 3,143.85 0 Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study) 01/23/2018 INTERVENTIONAL unchanged 3,137.85 0 Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study 01/24/2018 OBSERVATIONAL unchanged 3,136.85 0 Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery 01/24/2018 OBSERVATIONAL unchanged 3,136.85 0 Perioperative Music Listening on Anxiety, Pain, Analgesia Use and Patient Satisfaction 01/30/2018 INTERVENTIONAL unchanged 3,130.85 0 Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD 01/31/2018 INTERVENTIONAL unchanged 3,129.85 0 Accelerated iTBS for Post Partum Depression 01/31/2018 INTERVENTIONAL unchanged 3,129.85 0 Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy 02/01/2018 INTERVENTIONAL unchanged 3,128.85 0 Study Looking at Biomarkers in Ovarian Cancer 02/05/2018 INTERVENTIONAL unchanged 3,124.85 0 Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma 02/05/2018 INTERVENTIONAL unchanged 3,124.85 0 Exercise, Fitness and Tumor Profiling in Breast Cancer Patients 02/07/2018 OBSERVATIONAL unchanged 3,122.85 0 Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer 02/08/2018 INTERVENTIONAL unchanged 3,121.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology